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ABSTRACT
Sensitization of colorectal afferents and colorectal hypersensitivity have been
observed in a mouse model of post-infectious irritable bowel syndrome via
intracolonic treatment of 2,4,6-trinitrobenzenesulfonic acid (TNBS). In this study, we
investigated the distribution and morphology of microscopic colorectal afferent
endings before and after intracolonic treatment of TNBS. We genetically labeled
predominantly extrinsic colorectal afferents using the vesicular glutamate transporter
type 2 (VGLUT2) promoter. Then, we used an optical tissue clearing method of
whole-mount colorectum to image labeled VGLUT2-nerve endings that are otherwise
obscured in untreated samples. We used vector path tracing to quantify the density
and degree of curliness of colorectal nerve endings in various sub-volumes of the
colroectum captured via confocal imaging. VGLUT2-labeled nerve fibers were
observed in all layers except the serosa and longitudinal muscle, although they were
most abundantly present in the submucosa, myenteric plexus, and mucosa. Seven days
after TNBS treatment, the density of VGLUT2-positive neural tissues were
significantly reduced in these three layers. The TNBS-induced loss of VGLUT2 tissue
density recovered in most cases by day 28 of TNBS injection. Interestingly, almost all
VGLUT2-positive nerve endings in the submucosa displayed a much higher degree of
curliness compared to those in other layers in both the control and treated
colorectums. However, TNBS treatment significantly reduced the presence

of

severely curly nerve endings in the rectal region 28 days post-TNBS. The results from
this

morphological

study

along

with

previous

findings

of

functional

mechanotransduction studies point to the role of curly afferent endings in the
submucosa in the encoding of noxious visceral stimuli i.e. in visceral nociception.
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INTRODUCTION
Irritable Bowel Syndrome (IBS) is a chronic gastrointestinal (GI) disorder
that affects about 10-20% of the American population by disrupting normal bowel
movement and causing abdominal pain and discomfort (30). Despite the known
prevalence of IBS, its diagnosis and treatment remain challenging for physicians
globally due to the poor understanding of the mechanisms underlying the pain
experienced. The chief symptom that IBS patients report to gastroenterologists is
chronic visceral pain. In contrast to acute visceral pain, which likely indicates a
medical emergency due to physical damage in the viscera, chronic visceral pain
manifests without any apparent damage (7). The lack of apparent damage makes it
difficult to treat patients via surgical or clinical interventions. This leads to the
classification of disorders such as IBS

as “functional disorders” in which the

diagnosis is based on the symptoms but not on any detectable structural or
biochemical abnormalities (7).
Since patients present IBS-related visceral pain without any structural defects
or mechanical insult, alleviating symptoms requires focusing on the neural encoding
of the pain rather than surgical interventions. Clinical studies reveal that the persistent
sensitization of colorectal afferents is necessary to sustain the perception of chronic
visceral pain in IBS patients (21, 31, 32). Preclinical rodent models have
demonstrated that sensitized colorectal afferents result in behavioral visceral
hypersensitivity (7, 22, 24, 29). Subthreshold firing of both mechanosensitive and
mechanically insensitive extrinsic colorectal afferents, induced by treatment with
2,4,6-trinitrobenzenesulfonic acid (TNBS), is correlated with behavioral changes (8).
Specifically, the

TNBS mouse model introduces post-infectious irritable bowel

syndrome (PI-IBS) symptoms such as afferent sensitization and behavioral
hypersensitivity.
Visceral pain is unique in that it is generally caused by mechanical stimuli
such as colorectal distension in IBS. However, other types of stimuli such as cutting,
pinching, and heat are not sufficient at evoking visceral pain (7). Therefore,
mechanotransduction is a key research focal point when it comes to understanding
visceral pain. The transduction of colorectal distension into sensory information i.e.
conversion of mechanical information into action potentials, has been studied
3

extensively in colorectal afferents through extracellular single-unit recording studies
(6, 9, 11, 12), and less extensively in intracellular recordings from afferent cell bodies
in the dorsal root ganglion (DRG) (14, 20). The neural encoding measured in these
studies is initiated at the nerve endings found throughout the various layers of the
colorectal wall (9, 34). Despite their vital role in initiating the perception of both
physiological and pathophysiological information, colorectal afferent nerve endings
remain understudied.
Existing knowledge about colorectal nerve endings comes from dye-labelling
studies that reveal their physical locations and general morphology in layers through
the thickness of the colorectal wall (27, 28). In a previous study that used
immunohistochemistry, a general reduction of neuronal tissues was observed in the
colorectum seven days post-TNBS injection which recovered 14-28 days
post-injection (8). However, the extent to which the distribution, density, and
morphology of specifically extrinsic colorectal afferent endings are altered remains
unclear in IBS-related visceral hypersensitivity.
Extrinsic afferents, which originate in the DRG, are glutamatergic neurons and
thus express one of three vesicular glutamate transporter (VGLUT) subtypes
(VGLUT1, VGLUT2, and VGLUT3) (19). Specifically, colorectal afferents mainly
express VGLUT2 and remaining subtypes account for less than 10% of DRG
colorectal afferent neurons (3). Additionally, channelrhodopsin2 tagged with
fluorescent protein EYFP (ChR2-EYFP) was used in functional characterization
studies because it was found to be reliably transported to afferent endings (6, 34).
Therefore, in this study we quantified the morphological changes of afferent endings
post TNBS treatment in Cre-LoxP transgenic mice. We used Cre-LoxP transgenic
mice in which the VGLUT2 promoter drove the expression of ChR2-EYFP. We
found that 78% of DRG afferent neurons were tagged with VGLUT2-Cre as opposed
to only 2.6% of myenteric neurons. This confirms that the VGLUT2 promoter drives
the expression of predominantly extrinsic afferents and a very small population of
enteric neurons. Following genetic labelling of VGLUT2-positive afferents, we
performed optical tissue clearing of whole-mount colorectums using a SeeDB protcol
(16) for confocal imaging, revealing fine nerve endings throughout the depth of the
colorectal wall. The 3-dimensional stacks acquired from confocal imaging allowed for
4

vector path tracing to study physical characteristics of individual nerve endings before
and after TNBS treatment.
METHODS
All experimental procedures were reviewed and approved by the University of
Connecticut Institutional Animal Care and Use Committee.
Optical clearing by adapting the SeeDB protocol
To optically clear the colorectum, we adopted the protocol published by Ke et. al,
which was originally developed for clearing mouse brain tissues (16). Briefly, the
fixed samples were rinsed with PBS for three times and then submerged in 20-30 mL
of 20%, 40%, 60%, 80%, 100% (wt/vol) fructose for 3h, 3h, 12h, 12h, and 24h,
respectively. Afterwards, the samples were submerged in SeeDB solution (80.2%
wt/wt fructose) for 24 h. The 20-100% fructose solutions were prepared with diluted
PBS solution (10 times dilution) and the SeeDB solution was prepared with deionized
H2O. The whole clearing process was conducted in a dark environment with sample
tubes placed on a gentle shaker at room temperature. Samples were further incubated
in a refractive index matching solution (RIMS, see (16) for details) overnight at 4 °C
and divided longitudinally into three 10-mm-long segments as shown in Fig. 1B, i.e.
the colonic, intermediate, and rectal regions (from proximal to distal) according to our
previous reports (26, 33). We mounted each segment in RIMS on glass slides and
sealed the coverslip with nail polisher. Incubating and mounting samples in RIMS
with an refractive index (RI) of ~1.47 enhanced the optical clarity by reducing the
mismatch of RIs between the processed sample and the glass microscope objective.
PI-IBS mouse model by intracolonic TNBS treatment
Mice were lightly anesthetized (isoflurane), and either saline or TNBS (0.2 ml @
10 mg/ml in 50% ethanol; Sigma-Aldrich, St. Louis, MO) was administered
transanally via a 22-gauge feeding needle with an oval-shaped tip of Ø1.25 mm
(#18061-22, Fine Science Tools, Foster City, CA). Under anesthesia, mice were held
in a head down position (~30°) for five minutes to ensure retention of TNBS in the
colon. After the injection of TNBS, access to food and water in the cage was
available. Our prior study indicated significant loss of nerve fibers in the colorectum
at day 7 post TNBS treatment and complete recovery by day 28 (8). Accordingly, we
5

designed the current study to assess nerve fiber density and morphology in
VGLUT2/ChR2 mice at days 7 and 28 post TNBS.
Tissue preparation for whole-mount optical clearing
Seven or 28 days after intracolonic TNBS or saline, mice were deeply
anesthetized (isoflurane), and euthanized by transcardiac perfusion from the left
ventricle with ice-cold oxygenated Krebs solution (in mM: 117.9 NaCl, 4.7 KCl, 25
NaHCO3, 1.3 NaH2PO4, 1.2 MgSO4, 2.5 CaCl2, and 11.1 D-glucose). The excised ~30
mm of distal colorectum was cannulated and distended to 20 mmHg with phosphate
buffered saline (PBS) using a custom-built distending device, an innocuous pressure
that prevents colorectal wall folding. The colorectum was distended for 1 minute,
rested for 1 minute, and distended/rested five times. After the distending protocol, the
colorectum generally displayed a cylindrical shape as shown in Fig. 1A. The
colorectum was then cut open along the mesentery and fixed with 4% (wt/vol)
paraformaldehyde (PFA, Sigma-Aldrich, St. Louis, MO) dissolved in PBS at 4 °C for
3 hours.
Whole-mount Immunostaining of the colorectum
To quantitatively determine the expression efficiency of the VGLUT2-Cre mice,
we conducted immuno-staining on the whole-mount colorectum harvested from both
VGLUT2/ChR2 and VGLUT2/tdT mice. Mice were euthanized via isoflurane
inhalation and perfused with a calcium-free Krebs solution containing 10 mM EDTA
and 1 µM nifedipine (Sigma-Aldrich, St. Louis, MO). Distal colons were harvested
and distended using the same distending protocol as described above. Inflated colons
were fixed in the tubular shape in 4% PFA at 4 °C for 30 min. The fixed tissues were
washed in PBS with 0.1% Triton X-100 (Sigma-Aldrich, St. Louis, MO) and then
incubated in a blocking solution containing 4% donkey serum, 0.4% Triton X-100 and
1% bovine serum in PBS for 45 minutes (4). To visualize neural somata, the tissues
were incubated with a mouse biotin-conjugated monoclonal antibody against
HuC/HuD (1:200, Fisher Scientific, East Greenwich, RI) for 48 hours at 4 °C, and
then were incubated in Streptavidin conjugated with Alexa Fluor 594 (1:200, Jackson
ImmunoResearch, West Grove, PA) for 2 hours at room temperature. The colorectum
was then flattened, whole-mounted on diamond white glass slides serosal side up
6

(Globe Scientific, Inc., Mahwah, NJ), covered by thin glass slips (Corning, Inc.,
Corning, NY), and imaged at the myenteric plexus using a confocal microscope
(A1R, Nikon Inc., Melville, NY).
Imaging throughout colorectal wall under confocal microscope
Cleared colorectal samples were mounted serosal side up in RIMS on diamond
white glass slides and covered by thin glass slips. The colorectal wall (thickness from
100 to 300 µm) was scanned from serosa to mucosa by Nikon A1R spectral confocal
microscope (Nikon Inc., Melville, NY) using a 40x Plan Fluor Oil immersion
objective (working distance 240 µm, NA 1.30). To capture fine structures of
unmyelinated nerve endings (~1 µm thick according to (18)), we scanned the sample
at 0.3 µm step size and 1024x1024 pixel resolution either through the wall thickness
or up to 200 µm, limited by the working distance of the 40x objective. We
implemented intensity correction in the Z direction to increase the scanning laser
power for deep tissues. We conducted image acquisition by setting the parameters in
the Nikon NIS-Elements software suite that came with the microscope. In each
sample, 2 image stacks were recorded at random locations. To avoid confounding
factors, areas with large blood vessels that showed strong autofluorescence were not
imaged.
Vector path tracing of VGLUT2-positive nerve fibers from image stacks
The 3-dimensional volume from confocal image stacks through the colorectal
wall was divided into sub-volumes following the anatomical separation of
longitudinal muscular, myenteric plexus, circular muscular, submucosal and mucosal
layers. In each sub-volume except the myenteric plexus, VGLUT2-positive nerve
fibers were traced using a semi-automated neurotracing plugin in ImageJ software
(version 1.8.0; NIH), i.e., “Simple Neurite Tracer” (18), which approximated each
curly nerve fiber with a vector path consisting of many linear segments. The traced
vector paths were extracted as x, y and z coordinates at the ends of the full path as
well as their lengths to allow post-hoc statistical analysis of nerve fibers. Vector path
tracing was not performed in the myenteric plexus, where nerve fibers clustered into
thick bundles to prevent definitive tracing of individual fibers.
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Quantification of VGLUT2-positive nerve fibers
Nerve fiber density quantified as length per volume - After vector path tracing, the
densities of VGLUT2-positive nerve fibers in the longitudinal muscular, circular
muscular, submucosal and mucosal layers were calculated as total nerve fiber length
divided by tissue volume. The total fiber length in each tissue volume was acquired
by summing all traced vector paths within the volume.
Nerve fiber density quantified as percentage of fluorescent signals - Unlike other
layers of the colorectum, many VGLUT2-positive nerve fibers organize into thick
bundles that weave into a mesh-like network; individual nerve fibers cannot be
definitively traced in those bundles. Thus, we quantified the VGLUT2-positive nerve
tissue density in the thin myenteric plexus as the area percentage of fluorescent
signals. Detection of the fluorescent signal threshold was reported previously (13).
Using ImageJ, we projected each myenteric plexus image stack with “maximum
intensity z-projection” to convert it into an 8-bit grayscale image. The threshold was
set to exclude at least 99.99% of the background intensity based on its Gaussian
distribution. The threshold value was calculated from the standard normal distribution
(Z) equation: threshold=3.72 SD + m, where 3.72 was the Z- score at P = 0.9999, SD
and m were the Standard Deviation and mean of background intensities in 8-bit
grayscale (0-255), respectively. The percentage of fluorescent signals was calculated
as the area ratio above the threshold in the 8-bit grayscale image.
Fiber ending curliness - The distal afferent endings (50 to 300 µm) in the
colorectum are putative transducer zones for encoding external stimuli into trains of
action potentials. Many of the distal VGLUT2-positive nerve endings are curly and
“meandering”, suggesting their mechano-nociceptive roles for encoding only noxious
and tissue-injurious colorectal deformation. From vector path tracing, we defined the
“curliness” of individual nerve endings (c) as the ratio between the ending path length
and the direct distance between the two ends of the endings:
c=

L

√(x2−x1) +(y2−y1) +(z2−z1)
2

2

2

where L is the nerve ending length, and (x1, y1, z1) and (x2, y2, z 2) are
coordinates of the two ends. The curliness c is 1 for an ideally straight nerve ending,
and greater than 1 for curly and meandering endings.
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Data analysis
Data were presented as means ± SD. One-way and two-way analysis of variance
(ANOVA) were used to test the differences between control and treated groups.
Differences were considered significant when p value<0.05. Statistical analysis was
performed using SigmaPlot version 9.0 (Systat Software, San Jose, CA).
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RESULTS
Optical clearing of mouse colorectum for through-thickness imaging
As shown in Fig. 1A, the colorectum is distended by 20 mmHg pressure
(threshold for physiologically noxious distension) following the protocol described in
Methods. As displayed in bright field photographs in Fig. 1B, the cleared colorectum
shows more glass-like transparency than the uncleared counterpart. Displayed in Fig.
1C is a comparison of z-stack confocal microscope images of uncleared (125 µm) and
cleared (78 µm) colorectal walls from VGLUT2/ChR2 mice. Thick nerve bundles in
the myenteric plexus are captured in the uncleared colorectum, but individual microns
thick nerve endings are only visible in the cleared colorectum (marked by the white
arrowhead) and obscured in the uncleared counterpart.

Fig. 1. Optical clearing of the mouse colorectum for through-thickness imaging.
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Validation of VGLUT2 expression in colorectal nerve innervations
Displayed in Figs. 2A and 2B are confocal images from cleared colorectum
harvested from VGLUT2/tdT and VGLUT2/ChR2 mice, respectively. Both reporter
lines reveal comparable VGLUT2-positive neural tissue patterns in the myenteric
plexus, i.e., the mesh-like thick nerve bundles connecting the myenteric ganglions.
However, the tdT reporter is inferior at labeling the individual fine fibers in the
submucosal layer as compared with the ChR2 reporter. Both tdT and ChR2 reporter
lines are efficient in labeling the cell somata in the myenteric ganglion as indicated by
arrowheads in Figs. 2A and 2B. Thus, we used both reporter lines to quantify the
proportions of positive neurons in the myenteric plexus and exclusively used the
VGLUT2/ChR2 mice for quantification of nerve endings in the colorectum.

Fig. 2. Validation of VGLUT2 expression in colorectal nerve innervations.
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In our previous study using the tdT reporter line, we reported that VGLUT2-Cre
induced the expression of 68% of colorectal afferent neurons in the DRG (13). To
assess the expression efficiency in the enteric nervous system, we marked the neural
somata with anti-Hu antibody as shown in Fig. 2C, which reveals that VGLUT2-Cre
only induced the expression in a very small fraction of myenteric neurons
(2.62±1.88%, 7/266 in total, quantified in 5 myenteric ganglions). We did not observe
any VGLUT2-positive somata in the submucosal plexus (data not shown), consistent
with our prior antibody-based immuno-staining results (3). The above results
collectively indicate that nerve fibers in the VGLUT2/ChR2 colorectum consist of
mostly extrinsic sensory afferents and a small fraction of intrinsic myenteric fibers.

Through-thickness imaging of VGLUT2-positive fibers in the colorectum
Image stacks of VGLUT2-positive fibers in cleared colorectum were taken via
confocal microscopy at 0.3 µm step through the wall thickness from the serosal to the
mucosal side, or up to 200 µm (limited by the working distance of the 40x objective).
Displayed in Fig. 3 are typical z-stack images at five anatomically distinct layers of
the colorectum: mucosal (M), submucosal (SM), circular muscular (CM), myenteric
plexus (MP), and serosal & longitudinal muscular (S-LM) layers. VGLUT2-positive
nerve fibers are abundantly present at submucosal and myenteric plexus layers, which
coincide with

regions of the

two

enteric

plexuses in the

colorectum.

VGLUT2-positive nerve fibers are also widely present around the crypts in the
mucosal layer and present to a lesser degree in the circular muscular layers. No nerve
fibers are definitively embedded in the muscle bundles in the longitudinal muscular
layer. Also, no VGLUT2-positive fibers are detected in the serosal layer. Typical
images of VGLUT2-positive fibers in colorectums harvested at day 7 and 28 post
TNBS treatment are also displayed in Fig. 3. In the colorectums harvested from day 7
post

TNBS,

we

detected

regions with apparently

reduced numbers

of

VGLUT2-positive nerve fibers as indicated by the white arrowheads. In colorectums
from day 28 post TNBS, we did not observe an apparent reduction of
VGLUT2-positive nerve fibers in any layer.
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Fig 3. Typical confocal images were taken from colorectums harvested from control
and TNBS-treated mice at day 7 (TNBS-D7) and day 28 (TNBS-D28). M: mucosa,
SM: submucosa, CM: circular muscular layer, MP: myenteric plexus, S-LM: serosal
& longitudinal muscular layer.
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Quantification of the density of VGLUT2-positive nerve fibers in the colorectum
As described in Methods, we quantified the density of nerve fibers in the
myenteric plexus by calculating the area fraction of VGLUT2-positive fluorescent
signals. Displayed in Fig. 4A is a representative image stack of a 25 μm-thick
myenteric plexus, which was transformed into an 8-bit z-stack image (intensity from 0
to 255) and further converted into a binary image by setting a detection threshold
based on the mean (3.619) and standard deviation (1.379) of the background intensity.
The area fraction of the VGLUT2-positive nerve fibers was determined by dividing
the mean intensity of the binary image 58.007 by 255, i.e., 22.75%.

Fig. 4. Quantification of the density of VGLUT2-positive nerve fibers.
In contrast, fiber density in muscularis, submucosa, and mucosa was
quantified by vector path tracing using the “simple neurite tracer” plug-in in ImageJ.
As shown in a typical example in Fig. 4B, individual free nerve endings (marked by
arrow) and thick nerve bundles consisting of many axons (marked by double-arrow)
were both present in the tissue. For consistent analysis, we only quantified free nerve
endings and did not include nerve bundles in the analysis. The total length of free
nerve fibers in Fig. 4B is 4036 µm in a volume of 2.180×106 (322.18×322.18×21)
µm3, resulting in a fiber density of 1.85 m/mm3.

14

As summarized in Fig. 5, the density of VGLUT2-positive fibers was
determined at random locations in the colonic, intermediate and rectal segments of
five colorectums harvested from control VGLUT2/ChR2 mice receiving intracolonic
saline treatment. VGLUT2-positive nerve density in the myenteric plexus (MP),
circular muscular (CM), and mucosal (M) layers is comparable in all three
longitudinal segments. In contrast, nerve density in the submucosal (SM) layer is
significantly higher in the colonic segment than in the other two distal segments (p
<0.001). Nerve fibers are absent in the serosal & longitudinal muscular (S-LM) layers
in all three longitudinal segments.
In the colonic segments, nerve fiber density in the CM layer is significantly
lower than in the SM and M layers. In the intermediate segments, the fiber density in
the CM and SM layers were comparable but significantly lower than in the M layer.
In rectal segments, the fiber density in the CM layer was lower than in the M layer but
comparable with the fiber density in the SM layer. Overall, the nerve fiber density is
the lowest in the CM layer in all three segments.

Fig. 5. VGLUT2-positive nerve fiber densities quantified as nerve length per unit
volume in serosal & longitudinal muscular (S-LM), circular muscular (CM),
submucosal (SM) and mucosal (M) layers. As indicated with blue bars, neural tissue
density in the myenteric plexus (MP) was quantified as the area fraction of positive
fluorescent signals shown in the right y axis. n is the number of image stacks in each
bar graph.
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Loss (day 7) and recovery (day 28) of VGLUT2-positive nerve fibers following
intracolonic TNBS treatment
As shown in Fig. 6A, nerve fiber density in circular muscular layers is unaffected
by TNBS treatment in all three longitudinal segments. In contrast, nerve fiber density
is significantly reduced for the TNBS D7 group in the myenteric plexus (MP, Fig.
6B), submucosa (SM, Fig. 6C) and mucosa (M, Fig. 6D) in all three longitudinal
segments. In the TNBS-D28 group, nerve fiber densities completely recovered to the
control level in most SM, MP, and M layers. In some areas, nerve density did not
fully recover at day 28 post TNBS, including in colonic SM (p =0.003), colonic M (p
= 0.108) and intermediate M (p = 0.158).

Fig. 6. Altered VGLUT2-positive neural signals in all layers of the colorectum
following intracolonic TNBS treatment. The neural densities in control and
TNBS-treated colorectums (day 7 and day 28) were quantified in circular muscular
(A), myenteric plexus (B), submucosal (C) and mucosal layers (D). n is the number of
image stacks in each bar graph. *: significant difference from control.
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TNBS impact on nerve endings curliness in submucosa
Unlike the VGLUT2-positive nerve fibers in other layers of the colorectum that
are generally aligned with the basal tissues (e.g., along the circular muscle bundles or
around the crypts), fibers in the submucosa do not seem to follow any patterns and are
significantly more meandering and curly. Here, we quantified the curliness in all
distal nerve endings in the submucosa following the description in Methods. We
analyzed the curliness of a total of 1148 VGLUT2-positive fibers from 5 control, 10
TNBS-D7, and 8 TNBS-D28 colorectums. Among the 1148 fibers, 1127 (98.2 %)
show curliness between 1 and 3, which are arbitrarily divided into three groups as
fibers with moderate (1 – 1.67), severe (1.67 – 2.33) and extreme curliness (2.33 – 3).
Displayed in Fig. 7A are typical examples of fibers from those three groups. As
shown in Fig. 7B, most of the fibers (>84%) have moderate curliness which was
unaffected by the TNBS treatment in either proportions or average curliness. The
proportions of fibers with severe curliness vary from 9.9 to 15.98% across different
groups. In the TNBS-D7 group, the proportion of severe curliness fibers present a
negative trend as compared to the control group in all three longitudinal segments
despite no statistical significance (Fisher’s exact test, p = 0.096 for colonic, p = 0.338
for intermediate, p = 0.213 for rectal vs. control). In the TNBS-D28 group, the
proportion of fibers with severe curliness is comparable to the control level at the
colonic and intermediate segments (14.02%, p = 1.000 for colonic; 11.67%, p = 0.830
for intermediate vs. control). However, the proportion of fibers with severe curliness
is significantly lower than the control level in the rectal segment (4.07%, p <0.001).
The proportion of fibers with extreme curliness is insignificant in all groups (<4.3%)
and was not analyzed. Pooling the curliness from all three segments, there is no
statistical difference between the average curliness in control, TNBS-D7 and
TNBS-D28 groups, which were 1.47 (n=
 472), 1.42 (n=
 202), and 1.31 (n=
 474),
respectively.
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Fig. 7. Quantification of the curliness of nerve endings in the submucosa
following intracolonic TNBS treatment. A) Typical submucosal nerve endings with
different levels of curliness, i.e., moderate (1-1.67, green), severe (1.67-2.33,
magenta), and extreme (2.33-3, cyan). Scale bars, 50 µm. B) The curliness histograms
of 1127 fibers ranging from 1 to 3 (21 fibers with curliness beyond 3 were excluded).
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DISCUSSION
The main innovation is this study was to systematically label a majority of
extrinsic colorectal afferents and study their morphological properties in healthy and
disease states. This is a significant advancement from prior studies that sparsely
labeled afferents using anterograde and retrograde transport of dyes to and from the
colon, respectively (2, 28, 33). The morphological study of extrinsic colorectal
afferent endings in the colon has traditionally been limited due to the difficulty in
selectively labeling them. We observed that while tdTomato efficiently labeled cell
bodies of colorectal afferents in the DRG, it was inefficient at labeling finer nerve
endings. On the other hand, channelrhodopsin tagged with EYFP efficiently labeled
finer nerve endings which are widely distributed throughout the depth of the
colorectal wall. It appears that proteins such as channelrhodopsin that are either
present in the plasma membrane or transported to it are better at labelling axons and
nerve endings, whereas cytoplasmic proteins such as tdTomato are better at labelling
cell bodies of neurons in the DRG.
The study of whole-mount colorectum has also been limited in the past by
challenges associated with extensively clearing the tissue. We observed that the
widely used clearing method known as CLARITY and similar detergent based
methods were not effective at clearing the colorectum for visualization of nerve
endings embedded in the wall (15). On the other hand SeeDB, a clearing method
usually utilized to clear brain tissues (16) was used in this study to succesfully clear
whole colorectums. Our study has highlighted SeeDB as a convenient alternative to
traditional optical

tissue clearing

methods for

future neurogastrointestinal

investigations.
Our findings about the relative distribution of extrinsic afferent endings in the
colorectum are consistent with a sparse labeling study that identified the submucosa
as the region with the highest density of afferent endings (28). Recently, the
submucosa has been identified as the load-bearing structure of the colon (25, 26). The
high density of VGLUT2-positive nerve endings in the submucosa and their unique
levels of curliness point to their potential role in visceral nociception. From
vector-path tracing, we found that submucosal nerve endings remain less stretched,
19

with an average degree of curliness of 1.47 when the colon was distended at
20mmHg, which is considered the threshold for noxious distention in the mouse
colon. Thus, at physiological levels of distension, the submucosal nerve endings likely
remain loose and not engaged in mechanotransduction.
In conclusion, we genetically labeled a majority of extrinsic colorectal
afferents by inducing the expression ChR2-EYFP in VGLUT2-CRE mice. Then, we
used the SeeDB optical tissue clearing protocol to allow for much more efficient
confocal microscopy through the depth of the colorectal wall. Using a semi-automated
vector-path tracing plugin in most regions of the colorectal wall and analysis of the
VGLUT2-positive fluorescent signals in the myenteric plexus, we compared the
relative density of VGLUT2-positive nerve tissue in control colorectums as well as
TNBS-treated ones. VGLUT2-positive nerve endings were found in all layers of the
wall except for serosa and longitudinal muscle layers. To better characterize the
morphology of submucosal nerve endings, we quantified the degree of curliness of
these endings before and after TNBS treatment. Intracolonic TNBS treatment
significantly reduced the nerve fiber density seven days later in all layers except in the
serosa and circular muscle layers, followed by recovery in most layers 28 days after
injection. Most submucosal nerve endings display some level of apparent curliness of
which about 10% display severe curliness. The proportion of severely curly fibers is
significantly reduced in TNBS day 7 colorectums and does not recover in TNBS day
28 rectal colorectums. These findings point to the potential for sensitization of certain
submucosal nerve endings when challenged with noxious colorectal distension. The
mechanism for sensitization of mechanosensitive afferent endings and high-threshold
afferent endings should be validated in future studies by studying the changes to
submucosal afferents under noxious colorectal distension levels higher than 20mmHg.
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